1
40
15
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<table width="91" style="border-collapse:collapse;width:68pt;"><colgroup><col width="91" style="width:68pt;" /></colgroup><tbody><tr style="height:15pt;"><td width="91" height="20" class="xl18" style="width:68pt;height:15pt;"><a href="http://doi.org/10.1097/DCR.0000000000002071">http://doi.org/10.1097/DCR.0000000000002071</a></td>
</tr></tbody></table>
Pages
1083-1095
Issue
9
Volume
64
NEOMED Department
Department of Pathology
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
Creator
An entity primarily responsible for making the resource
O'Brien SJ; Kalbflesich T; Srivastava S; Pan J; Rai S; Petras RE; Ronquillo N; Polk HC; Galandiuk S
Publisher
An entity responsible for making the resource available
Diseases Of The Colon And Rectum
Date
A point or period of time associated with an event in the lifecycle of the resource
2021
Description
An account of the resource
Colon cancer survival is dependent on metastatic potential and treatment. Large RNA-sequencing data sets may assist in identifying colon cancer-specific biomarkers to improve patient outcomes.
Subject
The topic of the resource
This study aimed to identify a highly specific biomarker for overall survival in colon adenocarcinoma by using an RNA-sequencing data set.
Identifier
An unambiguous reference to the resource within a given context
<table width="91" style="border-collapse:collapse;width:68pt;"><colgroup><col width="91" style="width:68pt;" /></colgroup><tbody><tr style="height:15pt;"><td width="91" height="20" class="xl18" style="width:68pt;height:15pt;"><a href="http://doi.org/10.1097/DCR.0000000000002071">http://doi.org/10.1097/DCR.0000000000002071</a></td>
</tr></tbody></table>
Format
The file format, physical medium, or dimensions of the resource
Journal Article
2021
Adenocarcinoma
Adenocarcinoma/*genetics
Aged
aquaporins
Biomarker
colonic neoplasms
Gene Expression
Kaplan-Meier Estimate
Neoplasm Staging
Proto-Oncogene Proteins B-raf/*genetics
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1111/j.1945-1474.2004.tb00534.x" target="_blank" rel="noreferrer noopener">http://doi.org/10.1111/j.1945-1474.2004.tb00534.x</a>
Pages
31–38
Issue
6
Volume
26
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Simulation of breast cancer screening: quality assessment of two protocols.
Publisher
An entity responsible for making the resource available
Journal for Healthcare Quality: Promoting Excellence in Healthcare
Date
A point or period of time associated with an event in the lifecycle of the resource
2004
2004-11
Subject
The topic of the resource
Female; Neoplasm Staging; American Cancer Society; Computer Simulation; Health Policy; Mammography; Human; Funding Source; Quality Assessment; Protocols; Breast Examination; Breast Self-Examination; Breast Neoplasms – Prevention and Control; Cancer Screening – Economics; Cancer Screening – Methods
Creator
An entity primarily responsible for making the resource
Carter KJ; Castro F; Kessler E; Erickson BA
Description
An account of the resource
Healthcare professionals must make breast cancer screening decisions without the help of clear answers in current medical knowledge. This study used computer simulation to evaluate two screening protocols. The American Cancer Society (ACS) protocol comprising self-breast examination, professional breast examination and annual mammography was evaluated versus annual mammography alone. The effective frequency of mammography and the cost in the ACS protocol doubles the cost of mammography alone. Breast self-examination and clinical breast examination contributes to increased cost without any added health effects. These study results could be applied by healthcare professionals to assist their decision making for breast cancer screening.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1111/j.1945-1474.2004.tb00534.x" target="_blank" rel="noreferrer noopener">10.1111/j.1945-1474.2004.tb00534.x</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2004
American Cancer Society
Breast Examination
Breast Neoplasms – Prevention and Control
BREAST self-examination
Cancer Screening – Economics
Cancer Screening – Methods
Carter KJ
Castro F
Computer Simulation
Erickson BA
Female
Funding Source
Health Policy
Human
Journal for Healthcare Quality: Promoting Excellence in Healthcare
Kessler E
Mammography
Neoplasm Staging
Protocols
Quality Assessment
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1016/j.soc.2010.04.007" target="_blank" rel="noreferrer noopener">http://doi.org/10.1016/j.soc.2010.04.007</a>
Pages
xv–xvi
Issue
3
Volume
19
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Preface.
Publisher
An entity responsible for making the resource available
Surgical Oncology Clinics of North America
Date
A point or period of time associated with an event in the lifecycle of the resource
2010
2010-07
Subject
The topic of the resource
Female; Neoplasm Staging; Breast Neoplasms – Pathology
Creator
An entity primarily responsible for making the resource
Mamounas E P
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/j.soc.2010.04.007" target="_blank" rel="noreferrer noopener">10.1016/j.soc.2010.04.007</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2010
Breast Neoplasms – Pathology
Female
Mamounas E P
Neoplasm Staging
Surgical Oncology Clinics of North America
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
5–15
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Improving Outcomes in Early-Stage Breast Cancer.
Publisher
An entity responsible for making the resource available
Oncology (08909091)
Date
A point or period of time associated with an event in the lifecycle of the resource
2010
2010-10-03
Subject
The topic of the resource
Physician-Patient Relations; Neoplasm Staging; Prognosis; Survival; Education; Practice Guidelines; Antineoplastic Agents; Adjuvant; Chemotherapy; Treatment Outcomes; Race Factors; Early Detection of Cancer; Lumpectomy; Continuing (Credit); Breast Neoplasms – Mortality; Breast Neoplasms – Pathology; Breast Neoplasms – Therapy; Breast Neoplasms – Classification; Breast Neoplasms – Psychosocial Factors; Hormonal – Therapeutic Use
Creator
An entity primarily responsible for making the resource
Glück Stefan; Mamounas Terry; Klem Jennifer
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2010
Adjuvant
Antineoplastic Agents
Breast Neoplasms – Classification
Breast Neoplasms – Mortality
Breast Neoplasms – Pathology
Breast Neoplasms – Psychosocial Factors
Breast Neoplasms – Therapy
Chemotherapy
Continuing (Credit)
Early Detection of Cancer
Education
Glück Stefan
Hormonal – Therapeutic Use
Klem Jennifer
Lumpectomy
Mamounas Terry
Neoplasm Staging
Oncology (08909091)
Physician-Patient Relations
Practice Guidelines
Prognosis
Race Factors
Survival
Treatment Outcomes
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1155/2019/3561501" target="_blank" rel="noreferrer noopener">http://doi.org/10.1155/2019/3561501</a>
Pages
1–8
NEOMED College
NEOMED College of Medicine
NEOMED Department
NEOMED Student Publications
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage.
Publisher
An entity responsible for making the resource available
Sarcoma
Date
A point or period of time associated with an event in the lifecycle of the resource
2019
2019-02-10
Subject
The topic of the resource
Neoplasm Staging; Odds Ratio; Age Factors; Survival; Confidence Intervals; Neoplasm Metastasis; Human; Multiple Regression; Chemotherapy; Chemoradiotherapy; Cox Proportional Hazards Model; Kaplan-Meier Estimator; Uterine Neoplasms – Diagnosis; Lymph Nodes – Pathology; Adjuvant – Trends; Adjuvant – Utilization; Leiomyosarcoma – Diagnosis; Leiomyosarcoma – Prognosis; Leiomyosarcoma – Therapy; Uterine Neoplasms – Prognosis; Uterine Neoplasms – Therapy
Creator
An entity primarily responsible for making the resource
Patel Dhara; Handorf Elizabeth; von Mehren Margaret; Martin Lainie; Movva Sujana
Description
An account of the resource
Objectives. The benefit of adjuvant chemotherapy in patients with localized uterine leiomyosarcoma (LMS) remains unclear due to a lack of randomized studies and data only from small retrospective series to rely on. We sought to identify factors associated with the administration of chemotherapy and to determine the trends in the usage of adjuvant chemotherapy in patients with nonmetastatic uterine LMS. Methods. Patients diagnosed with nonmetastatic uterine LMS between 2004 and 2014 were identified from the National Cancer Database (NCDB). Multiple regression was used to determine factors with a significant impact on patient receipt of chemotherapy. Kaplan–Meier curves and the Cox model were used to determine the effect of adjuvant chemotherapy on overall survival (OS). Results. 2,732 uterine LMS patients were identified. Patients older than 65 were less likely to receive chemotherapy than their younger counterparts. Patients with stage I or stage II cancer were less likely to receive chemotherapy, whereas individuals with positive regional lymph nodes and those who had received radiation were more likely. In this cohort, adjuvant chemotherapy had no significant impact on OS (HR, 1.04; 95% CI, 0.90–1.22; P=0.5768). However, administration of chemotherapy significantly increased from 2004 to 2014 (P\textless0.0001). Conclusions. Expected tumor characteristics such as higher stage of tumor were associated with receipt of chemotherapy. Although adjuvant chemotherapy demonstrated no benefit over observation on OS in patients with nonmetastatic LMS, the number of patients being treated with chemotherapy continued to increase from 2004 to 2014.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1155/2019/3561501" target="_blank" rel="noreferrer noopener">10.1155/2019/3561501</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2019
Adjuvant – Trends
Adjuvant – Utilization
Age Factors
Chemoradiotherapy
Chemotherapy
Confidence Intervals
Cox Proportional Hazards Model
Handorf Elizabeth
Human
Kaplan-Meier Estimator
Leiomyosarcoma – Diagnosis
Leiomyosarcoma – Prognosis
Leiomyosarcoma – Therapy
Lymph Nodes – Pathology
Martin Lainie
Movva Sujana
Multiple Regression
NEOMED College of Medicine Student
NEOMED Student Publications
Neoplasm Metastasis
Neoplasm Staging
Odds Ratio
Patel Dhara
Sarcoma
Survival
Uterine Neoplasms – Diagnosis
Uterine Neoplasms – Prognosis
Uterine Neoplasms – Therapy
von Mehren Margaret
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
264–271
Issue
1
Volume
7
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Overexpression of beta-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas.
Publisher
An entity responsible for making the resource available
International journal of clinical and experimental pathology
Date
A point or period of time associated with an event in the lifecycle of the resource
2014
1905-07
Subject
The topic of the resource
Adult; Female; Humans; Middle Aged; Aged; Young Adult; Immunohistochemistry; Neoplasm Staging; Prognosis; Kaplan-Meier Estimate; Up-Regulation; Biomarkers; beta-catenin; beta Catenin/analysis/*biosynthesis; Cyclin D1/analysis/*biosynthesis; cyclinD1; Ovarian Neoplasms/*metabolism/mortality/pathology; ovarian serous carcinoma; prognosis; Cystadenocarcinoma; Serous/*metabolism/mortality/pathology; Tumor/*analysis
Creator
An entity primarily responsible for making the resource
Wang Hai; Wang Haiyan; Makki Mohammad Shahidul; Wen Juanjuan; Dai Yingqing; Shi Qunli; Liu Qi; Zhou Xiaojun; Wang Jiandong
Description
An account of the resource
UNLABELLED: Ovarian serous cancer is the most common subtype of epithelial ovarian cancer, and is the leading cause of death from gynecologic cancer. There is an important need for exploration of diagnostic and prognostic markers for this disease. beta-catenin and cyclinD1 play central roles in the tumorigenesis for certain cancers. The role of beta-catenin and cyclinD1 in diagnosis and prognosis of ovarian serous carcinoma is uncertain. In the present study, the expression of beta-catenin and cyclinD1 was examined in 60 ovarian serous carcinomas patients with immunohistochemical staining. The relationship between expression of beta-catenin and cyclinD1 and FIGO stage, pathological grade was analyzed. Kaplan-Meier survival function was used to analyze the prognosis. Overexpression of beta-catenin is more often detected in patients with FIGO stage III and IV than in those with stage I, and II (P=0.003). No significant relationship was found between expression of beta-catenin and pathological grade (P=0.817). Positive expression of beta-catenin related to lower survival rate (P=0.034). The expression of cyclinD1 had no relationship with FIGO stage (P=0.829). Overexpression of cyclinD1 was positively to pathological grade (P=0.017) and survival rate (P=0.009). There is a significantly positive relationship between expression of beta-catenin and cyclinD1 (P=0.014). No statistical significance was found between expression of beta-catenin and cyclinD1 and other pathological parameters. CONCLUSIONS: Expression of beta-catenin and cyclinD1 may be used as predict markers for poor prognosis.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2014
Adult
Aged
beta Catenin/analysis/*biosynthesis
beta-catenin
Biomarkers
Cyclin D1/analysis/*biosynthesis
cyclinD1
Cystadenocarcinoma
Dai Yingqing
Female
Humans
Immunohistochemistry
International journal of clinical and experimental pathology
Kaplan-Meier Estimate
Liu Qi
Makki Mohammad Shahidul
Middle Aged
Neoplasm Staging
Ovarian Neoplasms/*metabolism/mortality/pathology
ovarian serous carcinoma
Prognosis
Serous/*metabolism/mortality/pathology
Shi Qunli
Tumor/*analysis
Up-Regulation
Wang Hai
Wang Haiyan
Wang Jiandong
Wen Juanjuan
Young Adult
Zhou Xiaojun
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
410–416
Issue
4
Volume
18
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
The use of radioisotope scans in the evaluation of primary lymphoma of bone.
Publisher
An entity responsible for making the resource available
Orthopaedic review
Date
A point or period of time associated with an event in the lifecycle of the resource
1989
1989-04
Subject
The topic of the resource
Adult; Female; Humans; Male; Middle Aged; Adolescent; Aged; Retrospective Studies; Neoplasm Staging; Radionuclide Imaging; Bone Neoplasms/*diagnostic imaging; Diagnosis; Differential; Lymphoma; Large B-Cell; Diffuse/*diagnostic imaging
Creator
An entity primarily responsible for making the resource
Leeson M C; Makely J T; Carter J R; Krupco T
Description
An account of the resource
Primary lymphoma of bone is a rare lesion comprising less than 5% of all malignant primary bone tumors. Because of this rarity, the diagnosis of this lesion based on clinical findings and standard radiographic evaluations is extremely difficult and may not be entertained until after a biopsy has been performed. We retrospectively reviewed the cases of 22 consecutive patients with a diagnosis of primary lymphoma of bone (appendicular and axial skeleton) who along with standard radiographic evaluations had a technetium 99 bone scan performed as part of the preoperative staging process. A characteristic pattern demonstrating an increased uptake of intense tracer concentration peripherally and a relatively cold central area was seen consistently in all cases. This uptake pattern is then reversed with use of a gallium 67 scan. Because of the ambiguity of plain radiographs in the evaluation of adult bone lesions, radioisotope bone scans should be used as a diagnostic aid in an attempt to obtain as much information as possible about the biologic behavior of the bony lesion prior to any surgical intervention.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
1989
Adolescent
Adult
Aged
Bone Neoplasms/*diagnostic imaging
Carter J R
Diagnosis
Differential
Diffuse/*diagnostic imaging
Female
Humans
Krupco T
Large B-Cell
Leeson M C
Lymphoma
Makely J T
Male
Middle Aged
Neoplasm Staging
Orthopaedic review
Radionuclide Imaging
Retrospective Studies
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.7150/thno.22502" target="_blank" rel="noreferrer noopener">http://doi.org/10.7150/thno.22502</a>
Pages
1678–1689
Issue
6
Volume
8
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Surface Enhanced Raman Spectroscopy (SERS) for the Multiplex Detection of Braf, Kras, and Pik3ca Mutations in Plasma of Colorectal Cancer Patients.
Publisher
An entity responsible for making the resource available
Theranostics
Date
A point or period of time associated with an event in the lifecycle of the resource
2018
1905-07
Subject
The topic of the resource
Adult; Female; Humans; Male; Middle Aged; Aged; *colorectal cancer; *gene; *mutation; *Mutation; *PCR; *surface enhanced Raman scattering; Class I Phosphatidylinositol 3-Kinases/blood/*genetics; Cluster Analysis; Colorectal Neoplasms/blood/*diagnosis/genetics/pathology; DNA Primers/chemistry; Exons; Multiplex Polymerase Chain Reaction/methods/standards; Neoplasm Staging; Proto-Oncogene Proteins B-raf/blood/*genetics; Proto-Oncogene Proteins p21(ras)/blood/*genetics; Biomarkers; Spectrum Analysis; Raman/methods/*standards; Tumor/blood/*genetics
Creator
An entity primarily responsible for making the resource
Li Xiaozhou; Yang Tianyue; Li Caesar Siqi; Song Youtao; Lou Hong; Guan Dagang; Jin Lili
Description
An account of the resource
In this paper, we discuss the use of a procedure based on polymerase chain reaction (PCR) and surface enhanced Raman spectroscopy (SERS) (PCR-SERS) to detect DNA mutations. Methods: This method was implemented by first amplifying
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.7150/thno.22502" target="_blank" rel="noreferrer noopener">10.7150/thno.22502</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*colorectal cancer
*gene
*Mutation
*PCR
*surface enhanced Raman scattering
2018
Adult
Aged
Biomarkers
Class I Phosphatidylinositol 3-Kinases/blood/*genetics
Cluster Analysis
Colorectal Neoplasms/blood/*diagnosis/genetics/pathology
DNA Primers/chemistry
Exons
Female
Guan Dagang
Humans
Jin Lili
Li Caesar Siqi
Li Xiaozhou
Lou Hong
Male
Middle Aged
Multiplex Polymerase Chain Reaction/methods/standards
Neoplasm Staging
Proto-Oncogene Proteins B-raf/blood/*genetics
Proto-Oncogene Proteins p21(ras)/blood/*genetics
Raman/methods/*standards
Song Youtao
Spectrum Analysis
Theranostics
Tumor/blood/*genetics
Yang Tianyue
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1371/journal.pone.0149420" target="_blank" rel="noreferrer noopener">http://doi.org/10.1371/journal.pone.0149420</a>
Pages
e0149420–e0149420
Issue
2
Volume
11
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
The Difference in Prognosis between Renal Sinus Fat and Perinephric Fat Invasion for pT3a Renal Cell Carcinoma: A Meta-Analysis.
Publisher
An entity responsible for making the resource available
PloS one
Date
A point or period of time associated with an event in the lifecycle of the resource
2016
1905-07
Subject
The topic of the resource
Female; Humans; Male; Neoplasm Staging; Odds Ratio; Prognosis; Neoplasm Invasiveness; Proportional Hazards Models; Intra-Abdominal Fat/*pathology; Kidney Neoplasms/*mortality/*pathology; Publication Bias; Carcinoma; Renal Cell/*mortality/*pathology
Creator
An entity primarily responsible for making the resource
Zhang Zhi-Ling; Yu Chun-Ping; Velet Liliya; Li Yong-Hong; Jiang Li-Juan; Zhou Fang-Jian
Description
An account of the resource
BACKGROUND: In the current Tumour-Node-Metastasis (TNM) classification system for renal cell carcinoma (RCC), both renal sinus fat invasion (SFI) and perinephric fat invasion (PFI) are defined as T3a, suggesting that the prognosis should be similar for the two pathologic findings. Several studies, however, have reported a worse prognosis for SFI in patients with a T3a tumor. In order to compare the prognosis of these two pathologic findings (SFI versus. PFI) in a more comprehensive way, this meta-analysis was performed. METHODS: To identify relevant studies, Medline, Embase, Cochrane Library, and Scopus database were searched from the inception until October 2014. A meta-analysis was performed using Review Manager 5.2 and STATA 11. Pooled Odds ratio (OR) and/or hazard ratio (HR) with 95% confidence interval (CI) were calculated to examine the risk or hazard association. RESULTS: A total of 6 studies including 1031 patients qualified for analysis. T3a RCC patients with SFI were significantly associated with poor cancer specific survival(CSS) (HR: 1.47, 95% CI: 1.19-1.83; P\textless0.001) compared to those with PFI. In T3aNx/N0M0 subgroup, SFI patients also showed a worse prognosis than those with PFI (CSS, HR: 1.94, 95% CI: 1.21-3.12; P = 0.006). T3a RCC patients with SFI had higher Furhman grade, greater possibility of lymph node metastasis, sarcomatoid differentiation and tumour necrosis. Main limitation is the relatively small number of included studies. CONCLUSION: The present meta-analysis suggested that SFI is associated with worse CSS in patients with pT3a RCC. However, due to the small number of included studies, future studies with a large sample size are required to further verify our findings.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1371/journal.pone.0149420" target="_blank" rel="noreferrer noopener">10.1371/journal.pone.0149420</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2016
Carcinoma
Female
Humans
Intra-Abdominal Fat/*pathology
Jiang Li-Juan
Kidney Neoplasms/*mortality/*pathology
Li Yong-Hong
Male
Neoplasm Invasiveness
Neoplasm Staging
Odds Ratio
PloS one
Prognosis
Proportional Hazards Models
Publication Bias
Renal Cell/*mortality/*pathology
Velet Liliya
Yu Chun-Ping
Zhang Zhi-Ling
Zhou Fang-Jian
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1111/j.1945-1474.2004.tb00534.x" target="_blank" rel="noreferrer noopener">http://doi.org/10.1111/j.1945-1474.2004.tb00534.x</a>
Pages
31–38
Issue
6
Volume
26
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Simulation of breast cancer screening: quality assessment of two protocols.
Publisher
An entity responsible for making the resource available
Journal for healthcare quality : official publication of the National Association for Healthcare Quality
Date
A point or period of time associated with an event in the lifecycle of the resource
2004
2004-12
Subject
The topic of the resource
*Clinical Protocols; *Computer Simulation; *Practice Guidelines as Topic; Adult; American Cancer Society; Breast Neoplasms/*diagnosis/epidemiology; Breast Self-Examination/*standards; Female; Health Care; Humans; Mammography/*standards; Mass Screening/*standards; Middle Aged; Neoplasm Staging; Quality Assurance; Time Factors; United States
Creator
An entity primarily responsible for making the resource
Carter Kimbroe J; Castro Frank; Kessler Edward; Erickson Barbara A
Description
An account of the resource
Healthcare professionals must make breast cancer screening decisions without the help of clear answers in current medical knowledge. This study used computer simulation to evaluate two screening protocols. The American Cancer Society (ACS) protocol comprising self-breast examination, professional breast examination and annual mammography was evaluated versus annual mammography alone. The effective frequency of mammography and the cost in the ACS protocol doubles the cost of mammography alone. Breast self-examination and clinical breast examination contributes to increased cost without any added health effects. These study results could be applied by healthcare professionals to assist their decision making for breast cancer screening.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1111/j.1945-1474.2004.tb00534.x" target="_blank" rel="noreferrer noopener">10.1111/j.1945-1474.2004.tb00534.x</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Clinical Protocols
*Computer Simulation
*Practice Guidelines as Topic
2004
Adult
American Cancer Society
Breast Neoplasms/*diagnosis/epidemiology
Breast Self-Examination/*standards
Carter Kimbroe J
Castro Frank
Erickson Barbara A
Female
Health Care
Humans
Journal for healthcare quality : official publication of the National Association for Healthcare Quality
Kessler Edward
Mammography/*standards
Mass Screening/*standards
Middle Aged
Neoplasm Staging
Quality Assurance
Time Factors
United States
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1016/S0194-5998(98)70188-3" target="_blank" rel="noreferrer noopener">http://doi.org/10.1016/S0194-5998(98)70188-3</a>
Pages
146–146
Issue
1
Volume
119
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Non-Hodgkin's lymphoma of the anterior maxillary gingiva.
Publisher
An entity responsible for making the resource available
Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Date
A point or period of time associated with an event in the lifecycle of the resource
1998
1998-07
Subject
The topic of the resource
*Diagnostic Errors; *Maxilla; Biopsy; Diffuse/*pathology/radiotherapy; Female; Gingival Neoplasms/*pathology/radiotherapy; Humans; Large B-Cell; Lymphoma; Middle Aged; Neoplasm Staging; Periodontal Abscess/*diagnosis
Creator
An entity primarily responsible for making the resource
Park Y W
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/S0194-5998(98)70188-3" target="_blank" rel="noreferrer noopener">10.1016/S0194-5998(98)70188-3</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Diagnostic Errors
*Maxilla
1998
Biopsy
Diffuse/*pathology/radiotherapy
Female
Gingival Neoplasms/*pathology/radiotherapy
Humans
Large B-Cell
Lymphoma
Middle Aged
Neoplasm Staging
Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Park Y W
Periodontal Abscess/*diagnosis
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1016/j.ygyno.2014.12.025" target="_blank" rel="noreferrer noopener">http://doi.org/10.1016/j.ygyno.2014.12.025</a>
Pages
508–515
Issue
3
Volume
137
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application.
Publisher
An entity responsible for making the resource available
Gynecologic oncology
Date
A point or period of time associated with an event in the lifecycle of the resource
2015
2015-06
Subject
The topic of the resource
*Mobile Applications; Adolescent; Adult; Aged; Breast Neoplasms/*therapy; Counseling/*methods; Diet; Endometrial cancer; Endometrial Neoplasms/*therapy; Exercise; Feasibility Studies; Female; Humans; Lifestyle; Middle Aged; Neoplasm Staging; Obesity/*therapy; Overweight/*therapy; Prospective Studies; Quality of Life; Surveys and Questionnaires; Survivors; Weight loss; Young Adult
Creator
An entity primarily responsible for making the resource
McCarroll Michele L; Armbruster Shannon; Pohle-Krauza Rachael J; Lyzen Amy M; Min Sarah; Nash David W; Roulette G Dante; Andrews Stephen J; von Gruenigen Vivian E
Description
An account of the resource
OBJECTIVE: The study aimed to assess a one-month lifestyle intervention delivered via a web- and mobile-based weight-loss application (app) (LoseIt!) using a healthcare-provider interface. METHODS: Early-stage overweight/obese (body mass index [BMI]\textgreater/=25kg/m(2)) cancer survivors (CS) diagnosed in the past three years, and without recurrent disease were enrolled and received exercise and nutrition counseling using the LoseIt! app. Entry and exit quality of life (FACT-G) and Weight Efficacy Lifestyle Questionnaire (WEL) measuring self-efficacy were measured along with anthropometrics, daily food intake, and physical activity (PA) using the app. RESULTS: Mean participant age was 58.4+/-10.3years (n=50). Significant reductions (p\textless0.0006) in anthropometrics were noted between pre- and post-intervention weight (105.0+/-21.8kg versus 98.6+/-22.5kg); BMI (34.9+/-8.7kg/m(2) versus 33.9+/-8.4kg/m(2)); and waist circumference (108.1+/-14.9cm versus 103.7+/-15.1cm). A significant improvement in pre- and post-intervention total WEL score was noted (99.38+/-41.8 versus 120.19+/-47.1, p=0.043). No significant differences were noted in FACT-G, macronutrient consumption, and PA patterns. CONCLUSION: These results indicate that a lifestyle intervention delivered via a web- and mobile-based weight-loss app is a feasible option by which to elicit short-term reductions in weight. Though these results parallel the recent survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED) trial, it is notable that they were achieved without encumbering significant cost and barrier-access issues (i.e. time, transportation, weather, parking, etc.).
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/j.ygyno.2014.12.025" target="_blank" rel="noreferrer noopener">10.1016/j.ygyno.2014.12.025</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Mobile Applications
2015
Adolescent
Adult
Aged
Andrews Stephen J
Armbruster Shannon
Breast Neoplasms/*therapy
Counseling/*methods
Diet
Endometrial cancer
Endometrial Neoplasms/*therapy
Exercise
Feasibility Studies
Female
Gynecologic oncology
Humans
Lifestyle
Lyzen Amy M
McCarroll Michele L
Middle Aged
Min Sarah
Nash David W
Neoplasm Staging
Obesity/*therapy
Overweight/*therapy
Pohle-Krauza Rachael J
Prospective Studies
Quality of Life
Roulette G Dante
Surveys and Questionnaires
Survivors
von Gruenigen Vivian E
Weight Loss
Young Adult
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1016/j.jaad.2009.07.026" target="_blank" rel="noreferrer noopener">http://doi.org/10.1016/j.jaad.2009.07.026</a>
Pages
499–506
Issue
3
Volume
63
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Spreading pigmented actinic keratosis: a review.
Publisher
An entity responsible for making the resource available
Journal of the American Academy of Dermatology
Date
A point or period of time associated with an event in the lifecycle of the resource
2010
2010-09
Subject
The topic of the resource
Actinic/diagnosis/*pathology; Biopsy; Carcinoma; Dermoscopy/methods; Diagnosis; Differential; Disease Progression; Female; Humans; Hutchinson's Melanotic Freckle/diagnosis/*pathology; Immunohistochemistry; Keratosis; Male; Needle; Neoplasm Staging; Precancerous Conditions/*pathology; Risk Assessment; Skin Neoplasms/diagnosis/*pathology; Squamous Cell/diagnosis/*pathology
Creator
An entity primarily responsible for making the resource
Uhlenhake Elizabeth E; Sangueza Omar P; Lee Andrew D; Jorizzo Joseph L
Description
An account of the resource
INTRODUCTION: Spreading pigmented actinic keratosis (SPAK) is a common, but uncommonly reported or appreciated, variant of classic actinic keratosis (AK). It can mimic different pigmented lesions, which may be benign (eg, solar lentigo) or malignant (eg, lentigo maligna). OBJECTIVE: We sought to review current data and identify areas needing further research to establish diagnostic guidelines for SPAK and to increase awareness of this common entity. METHODS: A literature search was performed in both PubMed and MEDLINE databases using the search terms "spreading pigmented actinic keratosis," "pigmented solar keratosis," "pigmented actinic," and "pigmented solar." Each article was retrieved, reviewed, and summarized. RESULTS: SPAK is a rarely reported lesion that can be difficult to distinguish from other benign and malignant pigmented lesions, including seborrheic keratosis, melanoma in situ (lentigo maligna type), and lentigo maligna melanoma. Located mainly on sun-exposed areas and with a size greater than 1.5 cm, the lesion typically spreads laterally. Pathologically, the lesion resembles classic AK with increased basal melanization. The malignancy potential has not yet been elucidated but destructive therapies such as cryotherapy are recommended. LIMITATIONS: Reports not yet published or not included in the comprehensive databases we used may exist that were not analyzed. CONCLUSIONS: SPAK can be associated with adjacent melanoma in situ; therefore, its diagnosis merits increased suspicion for coexisting melanoma.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/j.jaad.2009.07.026" target="_blank" rel="noreferrer noopener">10.1016/j.jaad.2009.07.026</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2010
Actinic/diagnosis/*pathology
Biopsy
Carcinoma
Dermoscopy/methods
Diagnosis
Differential
Disease Progression
Female
Humans
Hutchinson's Melanotic Freckle/diagnosis/*pathology
Immunohistochemistry
Jorizzo Joseph L
Journal of the American Academy of Dermatology
Keratosis
Lee Andrew D
Male
Needle
Neoplasm Staging
Precancerous Conditions/*pathology
Risk Assessment
Sangueza Omar P
Skin Neoplasms/diagnosis/*pathology
Squamous Cell/diagnosis/*pathology
Uhlenhake Elizabeth E
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1016/j.canlet.2010.01.030" target="_blank" rel="noreferrer noopener">http://doi.org/10.1016/j.canlet.2010.01.030</a>
Pages
1–12
Issue
1
Volume
294
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence.
Publisher
An entity responsible for making the resource available
Cancer letters
Date
A point or period of time associated with an event in the lifecycle of the resource
2010
2010-08
Subject
The topic of the resource
10-Dimethyl-1; 2-benzanthracene; 9; Animal; Animals; Biological; Breast Neoplasms – Chemically Induced; Breast Neoplasms – Diagnosis; Breast Neoplasms – Drug Therapy; Cell Division – Drug Effects; Cell Division/drug effects; Disease Models; Experimental/chemically induced/diagnosis/drug therapy; Experimental/drug therapy/pathology; Female; Glioblastoma/drug therapy; Glioma – Drug Therapy; Heterologous; Humans; Hydrocarbons; Male; Mammary Neoplasms; Metals; Metals – Diagnostic Use; Metals – Therapeutic Use; Models; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplasms – Diagnosis; Neoplasms – Drug Therapy; Neoplasms – Pathology; Neoplasms – Prevention and Control; Neoplasms/*diagnosis/drug therapy/prevention & control; Organometallic Compounds – Therapeutic Use; Organometallic Compounds/therapeutic use; Rats; Trace Elements – Diagnostic Use; Trace Elements – Therapeutic Use; Trace Elements/therapeutic use; Transplantation; Vanadium Compounds; Vanadium Compounds – Therapeutic Use; Vanadium Compounds/therapeutic use/toxicity; Vanadium/*therapeutic use/toxicity; Xenografts
Creator
An entity primarily responsible for making the resource
Bishayee Anupam; Waghray Abhijeet; Patel Mehool A; Chatterjee Malay
Description
An account of the resource
Vanadium, a dietary micronutrient, is yet to be established as an essential part of the human diet. Over the past century, several biological effects of vanadium, such as insulin-mimetic action as well as amelioration of hyperlipidemia and hypertension, have been discovered. This transition element is known to influence a battery of enzymatic systems, namely phosphatases, ATPases, peroxidases, ribonucleases, protein kinases and oxidoreductases. Multiple biochemical and molecular actions of vanadium have been implicated in its inhibitory effects on various tumor cells of human origin. Successful in vitro studies over the past few decades have advanced the anticancer research on vanadium into the preclinical stage. Vanadium in several animal cancer models provides protection against all stages of carcinogenesis–initiation, promotion, and progression. This review focuses on the current advances in cancer prevention and treatment as well as early detection by vanadium compounds in preclinical animal models while pointing to possible mechanisms of such diverse beneficial effects. Clinical pharmacokinetic and potential toxicity studies on vanadium are also highlighted in this review. Supporting and challenging evidence as well as future directions of vanadium research exploring the possibility of using this dietary agent for detection, prevention and treatment of human cancers are critically discussed.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/j.canlet.2010.01.030" target="_blank" rel="noreferrer noopener">10.1016/j.canlet.2010.01.030</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
10-Dimethyl-1
2-benzanthracene
2010
9
Animal
Animals
Biological
Bishayee Anupam
Breast Neoplasms – Chemically Induced
Breast Neoplasms – Diagnosis
Breast Neoplasms – Drug Therapy
Cancer letters
Cell Division – Drug Effects
Cell Division/drug effects
Chatterjee Malay
Disease Models
Experimental/chemically induced/diagnosis/drug therapy
Experimental/drug therapy/pathology
Female
Glioblastoma/drug therapy
Glioma – Drug Therapy
Heterologous
Humans
Hydrocarbons
Male
Mammary Neoplasms
Metals
Metals – Diagnostic Use
Metals – Therapeutic Use
Models
Neoplasm Staging
Neoplasm Transplantation
Neoplasms
Neoplasms – Diagnosis
Neoplasms – Drug Therapy
Neoplasms – Pathology
Neoplasms – Prevention and Control
Neoplasms/*diagnosis/drug therapy/prevention & control
Organometallic Compounds – Therapeutic Use
Organometallic Compounds/therapeutic use
Patel Mehool A
Rats
Trace Elements – Diagnostic Use
Trace Elements – Therapeutic Use
Trace Elements/therapeutic use
Transplantation
Vanadium Compounds
Vanadium Compounds – Therapeutic Use
Vanadium Compounds/therapeutic use/toxicity
Vanadium/*therapeutic use/toxicity
Waghray Abhijeet
Xenografts
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1002/hed.23647" target="_blank" rel="noreferrer noopener">http://doi.org/10.1002/hed.23647</a>
Pages
644–649
Issue
5
Volume
37
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Phase II study of gefitinib in patients with advanced salivary gland cancers.
Publisher
An entity responsible for making the resource available
Head & neck
Date
A point or period of time associated with an event in the lifecycle of the resource
2015
2015-05
Subject
The topic of the resource
80 and over; Adenocarcinoma/drug therapy/mortality/pathology; adenoid cystic carcinoma; Adenoid Cystic/*drug therapy/mortality/pathology; Adult; Aged; Antineoplastic Agents/*therapeutic use; Carcinoma; Disease-Free Survival; Dose-Response Relationship; Drug; Drug Administration Schedule; Female; gefitinib; Gefitinib; Humans; Local/*drug therapy/mortality/pathology; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness/pathology; Neoplasm Recurrence; Neoplasm Staging; non-adenoid cystic carcinoma; Prognosis; Quinazolines/*therapeutic use; Remission Induction; response to therapy; salivary gland cancer; Salivary Gland Neoplasms/*drug therapy/mortality/pathology; Survival Analysis; Treatment Outcome
Creator
An entity primarily responsible for making the resource
Jakob John A; Kies Merrill S; Glisson Bonnie S; Kupferman Michael E; Liu Diane D; Lee J Jack; El-Naggar Adel K; Gonzalez-Angulo Ana M; Blumenschein George R Jr
Description
An account of the resource
BACKGROUND: The purpose of this study was to determine the antitumor activity of the epidermal growth factor receptor (EGFR) inhibitor gefitinib in patients with recurrent/metastatic salivary gland cancer. METHODS: We conducted a phase II study in adenoid cystic carcinoma (ACC) and non-ACC. Gefitinib was administered 250 mg orally daily. The primary endpoint was tumor response. Secondary endpoints included progression-free survival (PFS), overall survival (OS), and disease control rates. EGFR and human epidermal growth factor receptor 2 (HER2) expression were evaluated and correlated with outcomes. RESULTS: Thirty-seven patients were enrolled in this study, and 36 were evaluable (18 with ACC and 18 with non-ACC). No responses were observed. Median PFS was 4.3 months and 2.1 months, and median OS was 25.9 months and 16 months for patients with ACC and non-ACC, respectively. The disease control rate at 8 weeks was higher in patients with ACC. No unexpected toxicities occurred. EGFR and HER2 overexpression did not correlate with outcomes. CONCLUSION: We did not observe significant clinical activity of gefitinib in advanced salivary gland cancer. NCT00509002.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1002/hed.23647" target="_blank" rel="noreferrer noopener">10.1002/hed.23647</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2015
80 and over
Adenocarcinoma/drug therapy/mortality/pathology
adenoid cystic carcinoma
Adenoid Cystic/*drug therapy/mortality/pathology
Adult
Aged
Antineoplastic Agents/*therapeutic use
Blumenschein George R Jr
Carcinoma
Department of Internal Medicine
Disease-Free Survival
Dose-Response Relationship
Drug
Drug Administration Schedule
El-Naggar Adel K
Female
Gefitinib
Glisson Bonnie S
Gonzalez-Angulo Ana M
Head & neck
Humans
Jakob John A
Kies Merrill S
Kupferman Michael E
Lee J Jack
Liu Diane D
Local/*drug therapy/mortality/pathology
Male
Maximum Tolerated Dose
Middle Aged
NEOMED College of Medicine
Neoplasm Invasiveness/pathology
Neoplasm Recurrence
Neoplasm Staging
non-adenoid cystic carcinoma
Prognosis
Quinazolines/*therapeutic use
Remission Induction
response to therapy
salivary gland cancer
Salivary Gland Neoplasms/*drug therapy/mortality/pathology
Survival Analysis
Treatment Outcome